Memory changes can come from many different causes: sleep loss, medication effects, thyroid disease, vitamin deficiencies, depression, delirium, stroke, neurodegenerative disease, alcohol use, infection, and more. Blood tests are often part of the first medical workup because they can uncover treatable problems that affect thinking, attention, energy, and day-to-day function.
Blood work does not diagnose most forms of dementia by itself. Instead, it helps clinicians look for medical contributors, rule out conditions that can mimic or worsen memory loss, and decide whether more testing is needed. A useful cognitive workup combines the story of the symptoms, a medication review, physical and neurological examination, cognitive testing, and sometimes brain imaging or specialized biomarkers.
Table of Contents
- Why Blood Tests Are Used
- Common Labs in Memory Workups
- What Abnormal Results Can Mean
- When Additional Blood Tests Are Ordered
- Alzheimer’s Blood Biomarker Tests
- How Labs Fit With Other Cognitive Tests
- How to Prepare for Blood Work
- When Memory Loss Needs Urgent Care
Why Blood Tests Are Used
Blood tests are used in memory loss evaluations to look for medical problems that can cause, imitate, or worsen cognitive symptoms. They are not a stand-alone answer, but they are a practical starting point because many common issues that affect the brain show up in routine lab work.
A person may describe “memory loss” when the main problem is actually attention, slowed thinking, word-finding difficulty, poor sleep, low energy, or confusion that comes and goes. Blood tests can help separate these patterns. For example, anemia can reduce stamina and concentration, thyroid disease can slow thinking or cause anxiety and restlessness, and low vitamin B12 can affect memory, mood, balance, and nerve function. Kidney or liver problems may allow waste products or medications to build up, leading to confusion or mental slowing.
Doctors also use labs to identify health conditions that raise the risk of cognitive decline over time. Diabetes, high cholesterol, chronic kidney disease, inflammation, and vascular risk factors do not automatically explain memory symptoms, but they can shape the overall assessment and treatment plan. A person with forgetfulness and uncontrolled blood sugar may need a different plan than someone with steadily progressive memory loss and normal routine labs.
Blood work is especially important when symptoms are new, changing quickly, or occurring alongside physical symptoms such as weight loss, fatigue, tremor, numbness, falls, fever, urinary symptoms, or a major change in mood. In these situations, the question is not only “Could this be dementia?” but also “Is there an active medical problem that needs treatment?”
A broader evaluation usually matters more than any single lab value. Clinicians look at how symptoms began, whether they are stable or worsening, whether daily functioning has changed, and whether another person has noticed changes. A structured visit for memory loss and confusion evaluation often includes questions about medications, alcohol use, sleep, mood, hearing, vision, falls, and safety at home.
It is also worth knowing what normal blood tests do not prove. Normal labs do not rule out Alzheimer’s disease, Lewy body dementia, frontotemporal dementia, vascular cognitive impairment, sleep apnea, depression, medication effects, or other neurological conditions. They simply make some medical explanations less likely and help guide the next step.
Common Labs in Memory Workups
Most memory workups begin with a focused set of routine blood tests rather than a large panel of rare-condition testing. The exact list varies by clinician, age, medical history, medications, and local guidelines, but several labs are commonly checked because they can reveal treatable contributors.
| Test | What it can help assess | Why it matters for memory symptoms |
|---|---|---|
| Complete blood count | Anemia, infection clues, platelet or white blood cell abnormalities | Low oxygen-carrying capacity, infection, or systemic illness can worsen fatigue, attention, and confusion. |
| Comprehensive metabolic panel | Kidney function, liver function, electrolytes, calcium, protein levels, glucose | Abnormal sodium, calcium, kidney, or liver results can cause confusion or mental slowing. |
| TSH, sometimes free T4 | Thyroid function | Hypothyroidism can slow thinking and energy; hyperthyroidism can cause anxiety, insomnia, and concentration problems. |
| Vitamin B12 | B12 deficiency or borderline status | Low B12 can affect cognition, mood, gait, balance, and nerve sensation. |
| Methylmalonic acid, sometimes homocysteine | Functional B12 deficiency when B12 is borderline | These can clarify whether a “low-normal” B12 level is clinically meaningful. |
| Folate | Folate deficiency | Deficiency can contribute to anemia and neurological or mood symptoms, depending on context. |
| Hemoglobin A1C or fasting glucose | Diabetes, prediabetes, blood sugar control | High or fluctuating blood sugar can affect energy, focus, vascular risk, and long-term brain health. |
| Lipid panel | Cholesterol and vascular risk | Vascular risk factors can contribute to stroke risk and vascular cognitive impairment. |
| ESR or CRP | Inflammation | May be useful when symptoms suggest inflammatory, infectious, autoimmune, or systemic disease. |
A complete blood count can show anemia, which may cause fatigue, weakness, shortness of breath, and poor concentration. It can also show clues of infection or bone marrow problems, although these usually need interpretation alongside symptoms and examination findings.
A metabolic panel is especially useful because the brain is sensitive to shifts in sodium, calcium, kidney function, liver function, and glucose. Very high or very low sodium can cause confusion. High calcium can cause sluggish thinking, constipation, thirst, and weakness. Poor kidney or liver function can change how medications are cleared, increasing the risk of side effects that look like cognitive decline.
Thyroid testing is common because thyroid disease can affect energy, mood, sleep, attention, and thinking speed. A person with hypothyroidism may feel slowed down, forgetful, depressed, cold, and fatigued. A person with hyperthyroidism may feel restless, anxious, shaky, sleepless, and unable to concentrate. Thyroid abnormalities are not the most common explanation for progressive dementia, but they are important to identify because treatment can improve overall function.
Vitamin B12 is another core test. B12 deficiency can cause memory complaints, depression-like symptoms, irritability, numbness or tingling, balance problems, and anemia. Some people have neurological symptoms even before anemia is obvious. If the B12 level is borderline, clinicians may add methylmalonic acid because it can better reflect whether the body is functionally short on B12. More detail on B12-related cognitive symptoms is discussed in vitamin B12 testing and brain fog.
Blood sugar testing is often included because both diabetes and episodes of low blood sugar can affect concentration and alertness. A1C gives a longer-term view of average blood sugar over roughly the past few months, while a glucose level reflects the time of testing. For people with cognitive complaints and fatigue, blood sugar and A1C testing can be especially relevant when symptoms fluctuate with meals, medication timing, or energy crashes.
What Abnormal Results Can Mean
An abnormal lab result may identify a treatable contributor, but it does not always fully explain memory loss. The key question is whether the abnormality fits the person’s symptoms, timeline, examination, medications, and other test results.
For example, a mildly low vitamin D level may be common and worth addressing for bone and general health, but it usually would not explain a clear pattern of progressive short-term memory loss by itself. In contrast, severe B12 deficiency with numbness, gait instability, anemia, and cognitive changes is much more likely to be clinically meaningful. Similarly, a slightly abnormal liver enzyme may need follow-up, but severe liver dysfunction with sleepiness, confusion, and medication sensitivity is a different situation.
Clinicians often think in terms of contributors rather than one single cause. An older adult may have mild cognitive impairment, untreated sleep apnea, low B12, hearing loss, and medication side effects at the same time. Treating the B12 deficiency may improve energy and nerve symptoms, while memory problems may still need cognitive follow-up. This is not a failed workup; it reflects how cognitive symptoms often have several layers.
Some abnormal results point toward urgent or time-sensitive problems. Very abnormal sodium, calcium, glucose, kidney function, liver function, infection markers, or medication levels can cause acute confusion, sometimes called delirium. Delirium is different from typical age-related forgetfulness because it develops over hours to days, fluctuates, and affects attention and awareness. A person may be unusually sleepy, agitated, disoriented, hallucinating, or unable to follow a conversation.
Other results are useful because they change long-term risk management. High A1C, high LDL cholesterol, kidney disease, and vascular risk factors may not explain every memory lapse, but they can influence prevention and treatment decisions. Vascular brain injury can accumulate silently, and reducing vascular risk is often part of protecting brain health.
A normal result can also be useful. If blood count, metabolic panel, thyroid function, and B12 are normal, the clinician may move more confidently toward cognitive screening, neuropsychological testing, sleep evaluation, psychiatric assessment, or brain imaging. For someone with progressive memory decline, normal routine labs should not end the evaluation.
Lab interpretation also depends on reference ranges and the individual. “Normal” ranges are based on populations, not perfect cutoffs for every person. Older adults, pregnant people, people with kidney disease, and people taking certain medications may need different interpretation. A borderline result may matter more when symptoms fit, and less when it appears unrelated.
This is one reason follow-up is important. A clinician may repeat a test, add a confirmatory lab, review old results for comparison, or treat a deficiency and monitor whether symptoms improve. Memory changes should be tracked over time, not judged from one lab report alone.
When Additional Blood Tests Are Ordered
Additional blood tests are ordered when the history, examination, age, risk factors, or pace of symptoms suggests something beyond the standard lab panel. More testing is not always better; the most useful tests are the ones linked to a specific clinical question.
Doctors may add infectious disease tests when there are risk factors or symptoms that make them relevant. Syphilis testing may be considered in some cognitive workups because neurosyphilis can affect cognition and behavior and is treatable. HIV testing may be appropriate when risk factors, age, immune symptoms, or the clinical picture raise concern. Lyme testing is usually reserved for people with plausible exposure and compatible symptoms, not for every person with memory loss.
Inflammatory and autoimmune testing may be considered when symptoms are unusual, rapidly progressive, or accompanied by headaches, seizures, fever, weight loss, rashes, joint swelling, abnormal neurological signs, or fluctuating psychiatric symptoms. Depending on the case, clinicians may order ESR, CRP, ANA, thyroid antibodies, autoimmune encephalitis antibodies, or other specialized tests. These are not routine screening tests for typical slowly progressive memory loss, but they can be important when the pattern is atypical.
Medication and toxicology-related tests can be very important. Some drugs can cause confusion, sedation, falls, or attention problems, especially in older adults or people with kidney disease. Blood levels may be checked for medications such as lithium, digoxin, certain antiseizure medicines, or other drugs with a narrow safe range. A toxicology screen may be used when substance exposure, overdose, or unexplained altered mental status is possible. This overlaps with broader toxicology screening in brain symptom workups.
Nutrition-related labs may be expanded when there is weight loss, alcohol use disorder, bariatric surgery, restrictive eating, malabsorption, neuropathy, or severe fatigue. In addition to B12 and folate, clinicians may consider thiamine, iron studies, ferritin, vitamin D, or other tests. Thiamine deficiency is especially important in people with heavy alcohol use, poor nutrition, or prolonged vomiting because severe deficiency can cause serious neurological symptoms.
Younger adults with memory loss may need a different approach than older adults. In a younger person, doctors may look more carefully for sleep disorders, autoimmune disease, epilepsy, medication effects, psychiatric conditions, substance use, hormonal issues, inflammatory disease, or rare genetic and metabolic conditions. A younger adult with cognitive symptoms and a strong family history of early dementia may be referred for specialist assessment and possibly genetic counseling rather than broad direct-to-consumer testing. The workup for memory loss in younger adults is often more individualized.
Rapidly progressive cognitive decline usually deserves prompt specialist evaluation. When memory, behavior, language, balance, or alertness changes over weeks to a few months, clinicians may consider additional blood tests, MRI, EEG, lumbar puncture, infectious testing, autoimmune testing, and other urgent investigations. The goal is to avoid missing treatable or dangerous causes.
Alzheimer’s Blood Biomarker Tests
Newer Alzheimer’s blood biomarker tests are different from routine labs such as CBC, thyroid, and B12. Instead of looking for general medical contributors, these tests look for blood-based signals associated with Alzheimer’s disease biology, such as amyloid and phosphorylated tau.
These tests are changing quickly, and their role depends on the setting. They may help specialists decide whether Alzheimer’s disease pathology is likely, whether a person needs confirmatory testing, or whether symptoms fit a biological Alzheimer’s profile. They are not the same as a routine “memory blood panel,” and they should not be interpreted without a clinical evaluation.
Common biomarker terms include amyloid beta ratios, p-tau181, p-tau217, p-tau231, glial fibrillary acidic protein, and neurofilament light chain. Different markers answer different questions. Some are more closely linked to amyloid or tau pathology, while others reflect neurodegeneration or brain injury more generally. A high neurofilament light chain result, for example, may suggest nerve cell injury but does not point only to Alzheimer’s disease.
A major limitation is that a biomarker result is not the same as a diagnosis. Alzheimer’s disease is diagnosed by combining symptoms, functional changes, cognitive testing, examination, and evidence about likely brain disease. A person may have Alzheimer’s-type biology and another condition contributing to symptoms. Another person may have memory symptoms caused mainly by depression, sleep apnea, medication effects, vascular disease, or another neurodegenerative disorder.
Blood biomarkers may be most useful when the clinical question is specific: Does this person with objective cognitive impairment have evidence suggesting Alzheimer’s disease pathology? They are less useful when used casually in people with no symptoms, vague worry, or normal cognitive testing. Testing without counseling can create confusion, especially if the result suggests risk rather than a clear explanation for current symptoms.
These tests also differ in quality. Not every commercially available test has the same validation, accuracy, or clinical role. Some require confirmation with amyloid PET, tau PET, or cerebrospinal fluid testing, especially when treatment decisions are being considered. Before ordering, patients should ask what the test measures, how accurate it is in people like them, what result would change, and whether a specialist should interpret it.
For readers comparing newer options, more focused discussions of Alzheimer’s blood biomarker tests, amyloid blood tests, and tau blood tests can help clarify how these tests differ from routine medical labs.
How Labs Fit With Other Cognitive Tests
Blood tests are only one part of a cognitive workup; they are most useful when combined with direct assessment of thinking, function, and brain health. A normal lab panel does not replace cognitive testing, and an abnormal lab does not always remove the need for further evaluation.
Most clinicians start by confirming whether there is objective cognitive impairment. Brief cognitive screening tests may include tools such as the MoCA, MMSE, Mini-Cog, SLUMS, or other structured measures. These tests look at memory, attention, language, orientation, visuospatial skills, and executive function. They do not diagnose the cause on their own, but they help show whether concerns are measurable and which thinking skills are most affected.
Functional history is just as important. Mild forgetfulness is different from missed bills, repeated medication errors, unsafe driving, getting lost in familiar places, leaving appliances on, or losing the ability to manage work tasks. A family member or close friend can often provide details that the person may not notice, especially when insight is affected.
When screening shows concerns, doctors may recommend more formal cognitive testing. Neuropsychological evaluation gives a deeper profile of strengths and weaknesses, which can help distinguish memory storage problems from attention problems, language disorders, executive dysfunction, depression-related cognitive symptoms, or patterns suggestive of a specific dementia syndrome. A detailed neuropsychological evaluation for memory loss is especially useful when the diagnosis is unclear, the person is younger, work capacity is affected, or baseline abilities are high.
Brain imaging may be ordered when symptoms are progressive, atypical, new, or accompanied by neurological signs. MRI is often preferred when available because it can show strokes, tumors, bleeding, hydrocephalus, patterns of atrophy, white matter disease, and other structural changes. CT may be used when MRI is not available or when faster imaging is needed. For some people, brain imaging for memory loss becomes a key part of deciding whether symptoms are likely due to vascular disease, neurodegeneration, or another structural problem.
Sleep and mood evaluations may also be needed. Depression can affect concentration, motivation, processing speed, and memory retrieval. Anxiety can make it hard to focus and encode new information. Sleep apnea can cause morning headaches, daytime sleepiness, irritability, and cognitive fog. Treating these conditions can improve quality of life and may improve cognitive performance, even when another diagnosis is also present.
The best workup usually answers three questions: Is there objective cognitive impairment? Are there treatable contributors? Is there evidence pointing toward a specific brain disease or condition? Blood tests mainly help with the second question, while cognitive testing, history, examination, imaging, and biomarkers help complete the picture.
How to Prepare for Blood Work
Preparation is simple for most memory-related blood tests, but a little planning can make the results easier to interpret. The most important step is to bring a complete medication and supplement list, including over-the-counter sleep aids, antihistamines, pain relievers, cannabis products, alcohol intake, and recent medication changes.
Ask whether fasting is needed. Many routine labs do not require fasting, but fasting may be requested for glucose or lipid testing depending on the clinician’s preference. If fasting is required, ask how long to fast and whether morning medications should be taken as usual. People with diabetes should get specific instructions so they do not risk low blood sugar.
Bring prior lab results if they were done elsewhere. Trends can matter more than a single value. A sodium level that is technically normal but much lower than usual, a slowly falling hemoglobin, or a worsening kidney result may be more meaningful when compared with earlier testing.
It can also help to write down the cognitive symptoms before the appointment. Include when they began, whether they are worsening, what daily tasks are affected, and whether symptoms fluctuate. Note any recent infections, falls, surgeries, hospitalizations, major stress, sleep disruption, diet change, or medication adjustment. A brief timeline can prevent important details from being missed.
Consider bringing a trusted person to the visit. Memory concerns can make medical instructions harder to remember, and another person may notice changes in driving, finances, cooking, conversation, or personality. This is not about taking control away from the patient; it is about improving the accuracy of the history and making follow-up safer.
After results return, avoid interpreting isolated abnormal values without context. Lab reports often flag small deviations that may not be clinically important. Conversely, a “normal” label may not fully answer the question if symptoms persist. A productive follow-up asks:
- Which results could plausibly affect memory, attention, or alertness?
- Do any results need treatment, repeat testing, or confirmation?
- Should symptoms be reassessed after treating an abnormality?
- Is cognitive screening, imaging, sleep evaluation, or specialist referral still needed?
- Are any medications or supplements increasing confusion risk?
If a deficiency or metabolic issue is treated, improvement may take time. Some symptoms, such as energy or sleep quality, may improve before memory does. Nerve symptoms from B12 deficiency can take longer, and some deficits may not fully reverse if deficiency has been prolonged. Follow-up testing helps confirm whether treatment corrected the abnormality.
When Memory Loss Needs Urgent Care
Memory loss needs urgent medical attention when it is sudden, rapidly worsening, or accompanied by signs of stroke, delirium, seizure, infection, head injury, or severe medication reaction. In these situations, waiting for a routine memory appointment can be unsafe.
Call emergency services or seek urgent care for sudden confusion, sudden trouble speaking, facial droop, weakness or numbness on one side, new severe headache, seizure, fainting, chest pain, high fever, stiff neck, severe dehydration, or confusion after a fall or head injury. These symptoms can reflect stroke, bleeding, infection, metabolic crisis, or another acute condition.
A sudden change in attention is especially concerning. Dementia usually develops gradually, while delirium often develops over hours to days and fluctuates. A person with delirium may be alert one moment and very drowsy or agitated later. They may not know where they are, may see or hear things that are not there, or may be unable to follow basic conversation. Common triggers include infection, dehydration, medication side effects, surgery, uncontrolled pain, constipation, urinary retention, low oxygen, and abnormal electrolytes.
Rapidly progressive memory or behavior change over weeks to a few months also deserves prompt evaluation, even if it is not an emergency in the moment. Warning signs include new seizures, major personality change, hallucinations, movement problems, repeated falls, severe headaches, unexplained weight loss, or rapidly declining ability to work, drive, manage money, or care for oneself.
Mental health safety matters too. Memory complaints sometimes occur alongside severe depression, hopelessness, paranoia, hallucinations, or thoughts of self-harm. If a person may harm themselves or someone else, or cannot safely care for basic needs, urgent evaluation is appropriate.
For less urgent but persistent symptoms, schedule a medical visit rather than relying on at-home memory tests or supplement trials. Bring a timeline, medication list, examples of functional changes, and any prior lab or imaging results. Blood tests can be very helpful, but the safest approach is a complete evaluation that treats reversible contributors while still looking carefully for neurological disease when the pattern suggests it.
References
- New Clinical Practice Guideline on the Process for Diagnosing Alzheimer’s Disease or a Related Form of Cognitive Impairment or Dementia 2024 (Guideline summary)
- Dementia: assessment, management and support for people living with dementia and their carers 2018, last reviewed 2025 (Guideline)
- Delirium: prevention, diagnosis and management in hospital and long-term care 2010, last updated 2023 (Guideline)
- General laboratory tests 2021 (Report chapter)
- A Neurologist’s Practical Approach to Cognitive Impairment 2021 (Review)
- Screening for Cognitive Impairment in Primary Care: Rationale and Tools 2023 (Review)
Disclaimer
This article is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Memory loss, confusion, rapid cognitive change, or abnormal lab results should be discussed with a qualified clinician who can interpret them in the context of symptoms, medications, examination findings, and overall health.
If you found this helpful, consider sharing it on Facebook, X, or your preferred platform so others can better understand what blood tests can and cannot show in a memory-loss workup.
